Skip to content

Clinical trials

Phase 3 Immune System Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Phase: Phase 3 Country / region: Germany Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20151
20162
20171
20183
20211
20221
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated4
Active, not recruiting3
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Pfizer2
Viatris Innovation GmbH2
Adienne SA1
Ariad Pharmaceuticals1
Baxalta now part of Shire1
Bristol-Myers Squibb1
Diamyd Medical AB1
Eli Lilly and Company1
La Jolla Pharmaceutical Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases16
Autoimmune Diseases9
Connective Tissue Diseases5
Lupus Erythematosus, Systemic5
Hypersensitivity4
Hypersensitivity, Immediate3
Asthma2
Bronchial Diseases2
Dermatitis2
Dermatitis, Atopic2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.